Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Resverlogix Corp
T.RVX
Alternate Symbol(s):
RVXCF
Healthcare
Biotechnology
Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the...
treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:RVX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
(106)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Post by
ENEMENEMYNEMO
on Oct 28, 2020 10:03pm
News Flash
News Flash There is no buy-out in the works! Unless the few of you are in the "know" ...in which case you wouldn't be posting here... 3d stage is done and showed nothing of value... I
...more
(7)
•••
Jesus4Prez
X
View Profile
View Bullboard History
Comment by
Jesus4Prez
on Oct 28, 2020 11:40am
RE:RE:RE:RE:Staged Buyout
Great question, no idea. It is all very curious! J4P
(75)
•••
QualityTest
X
View Profile
View Bullboard History
Comment by
QualityTest
on Oct 28, 2020 11:17am
RE:RE:RE:Staged Buyout
If someone wanted to buy us out that badly, why would they not have done that already? The data have been available since January about the SGLT2 synergies so that's been more than enough time for
...more
(7)
•••
Jesus4Prez
X
View Profile
View Bullboard History
Comment by
Jesus4Prez
on Oct 28, 2020 11:08am
RE:RE:Staged Buyout
I too can see Hepalink adding complication to strict partnership discussions. Interesting that Don has been in very frequent and direct conversation with them, important enough to stay up until
...more
(13)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Oct 28, 2020 7:18am
RE:RE:Staged Buyout
,,hummmm,,wouldn't Hepa have the best of both worlds,,,,,,,,,no additional dollars required to advance 208,,,,,,if success is met then they have the Chinese market to themselves,,possibly larger
...more
(106)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Oct 28, 2020 5:19am
RE:Staged Buyout
But how do you deal with the big elephant in the room out of China that no one wants to talk about? They have a licence to go out on their own in China, do they not? I suspect that SHL is
...more
(7)
•••
Jesus4Prez
X
View Profile
View Bullboard History
Post by
Jesus4Prez
on Oct 27, 2020 4:37pm
Staged Buyout
Would anyone agree with this thought: Don's Option 1 Development Plan sounds very much like a Contingent Value Rights deal, essentially a staged buyout with a floor price in place and
...more
(106)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Post by
ENEMENEMYNEMO
on Oct 27, 2020 1:15pm
Looking forward to November
https://www.globenewswire.com/news-release/2020/10/26/2114240/0/en/A-Second-Publication-Shortlists-Resverlogix-Clinical-Candidate-Apabetalone-for-its-Potential-COVID-19-Effectiveness-Including
...more
(17)
•••
fuzzyjr
X
View Profile
View Bullboard History
Comment by
fuzzyjr
on Oct 26, 2020 4:25pm
RE:RE:RE:RE:RE:RE:RE:RVX-Reducing Cytokine Storms-Short List
so much potential - really could be a "star factory" & hopefully behind the scenes things are a brewing in a positive manner.Another bonus - nothing better than a Drug that says '
...more
(17)
•••
fuzzyjr
X
View Profile
View Bullboard History
Comment by
fuzzyjr
on Oct 26, 2020 4:02pm
RE:RE:RE:RE:RE:RE:RVX-Reducing Cytokine Storms-Short List
summed it well narmac, maybe were one those biotech's that ho hums along with the pathetic volume ,under valued SP & flat lining , then BOOM - double digits $$ & then hearing the media
...more
(13)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Oct 26, 2020 3:47pm
RE:RE:RE:RE:RE:RVX-Reducing Cytokine Storms-Short List
,,,,aaaaccchhhh,,its me just showing frustration here,,,appologies to the board,,, I have no idea why we are range bound,,,it is not normal imo,.,,,,,,I have been investing and watching the market for
...more
(7)
•••
priceless2
X
View Profile
View Bullboard History
Comment by
priceless2
on Oct 26, 2020 1:33pm
RE:RE:RE:RE:RVX-Reducing Cytokine Storms-Short List
Narmac, I often wonder why RVX has not in a very very long time promoted the company to the mass media for the science potential in all areas of the science. Is it nobody cares to
...more
(59)
•••
snobei
X
View Profile
View Bullboard History
Comment by
snobei
on Oct 26, 2020 12:50pm
RE:RE:RE:RE:RVX-Reducing Cytokine Storms-Short List
Narmac im guessing ur a spot more knowledgeable on this stuff than i BUT, again, the only thing that will make the market accept our apology for missing these trial endpoints is meeting them or this
...more
(13)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Oct 26, 2020 12:33pm
RE:RE:RE:RVX-Reducing Cytokine Storms-Short List
,,,,,,even when we provide third party interesting data around covid we cant get interest in buying,,,,,there must be a fly in the ointment me thinks,,,,
(106)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Oct 26, 2020 9:28am
RE:RE:RVX-Reducing Cytokine Storms-Short List
If we're going to dream, let's dream big..haha! G1945V
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Nanalysis Scientific Corp. Announces First Quarter 2024 Results
This Small-Cap Gold Stock Jumped Almost 50% on Friday